| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| CA(L) | 130 | 53.1% | 0.40 | 171 | 52.8% |
| SLP(L) | 22 | 9.0% | 2.10 | 94 | 29.0% |
| CentralBrain-unspecified | 30 | 12.2% | 0.90 | 56 | 17.3% |
| PLP(L) | 30 | 12.2% | -3.32 | 3 | 0.9% |
| LH(L) | 30 | 12.2% | -inf | 0 | 0.0% |
| SCL(L) | 2 | 0.8% | -inf | 0 | 0.0% |
| Optic-unspecified(L) | 1 | 0.4% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns SLP184 | % In | CV |
|---|---|---|---|---|---|
| VP3+_vPN (L) | 1 | GABA | 91 | 42.3% | 0.0 |
| aMe23 (L) | 1 | Glu | 14 | 6.5% | 0.0 |
| LHPV4c1_b (L) | 4 | Glu | 9 | 4.2% | 0.4 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 8 | 3.7% | 0.0 |
| VP1m+VP2_lvPN2 (L) | 2 | ACh | 7 | 3.3% | 0.7 |
| M_ilPNm90 (L) | 1 | ACh | 6 | 2.8% | 0.0 |
| DL3_lPN (L) | 2 | ACh | 6 | 2.8% | 0.7 |
| DN1a (L) | 2 | Glu | 6 | 2.8% | 0.0 |
| VP5+Z_adPN (L) | 1 | ACh | 4 | 1.9% | 0.0 |
| LHPV4c1_c (L) | 3 | Glu | 4 | 1.9% | 0.4 |
| M_ilPNm90 (R) | 1 | ACh | 3 | 1.4% | 0.0 |
| LHPV4c1_a (L) | 1 | Glu | 3 | 1.4% | 0.0 |
| M_vPNml80 (L) | 1 | GABA | 3 | 1.4% | 0.0 |
| SMP421 (L) | 1 | ACh | 3 | 1.4% | 0.0 |
| SMP235 (L) | 1 | Glu | 3 | 1.4% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 3 | 1.4% | 0.0 |
| LHPV6q1 (L) | 1 | unc | 3 | 1.4% | 0.0 |
| CB3016 (L) | 2 | GABA | 3 | 1.4% | 0.3 |
| SMP049 (L) | 1 | GABA | 2 | 0.9% | 0.0 |
| VP2+_adPN (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| LoVP11 (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| DC2_adPN (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 2 | 0.9% | 0.0 |
| CB1976 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB1744 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB1326 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| KCg-s4 (L) | 1 | DA | 1 | 0.5% | 0.0 |
| LHAV2b6 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP410 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB1249 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SLP266 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| aDT4 (L) | 1 | 5-HT | 1 | 0.5% | 0.0 |
| LHPV6c1 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHAV5e1 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| M_lvPNm46 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHAV3o1 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| SLP076 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| LHAV6b4 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP189 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHPV4j4 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| SMP183 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LoVP67 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CSD (L) | 1 | 5-HT | 1 | 0.5% | 0.0 |
| PPL203 (L) | 1 | unc | 1 | 0.5% | 0.0 |
| VP1m_l2PN (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| PPL201 (L) | 1 | DA | 1 | 0.5% | 0.0 |
| DC1_adPN (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| WED092 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| downstream partner | # | NT | conns SLP184 | % Out | CV |
|---|---|---|---|---|---|
| DN1a (L) | 2 | Glu | 132 | 25.0% | 0.1 |
| LHPV4c3 (L) | 2 | Glu | 45 | 8.5% | 0.2 |
| LHAV3q1 (L) | 1 | ACh | 39 | 7.4% | 0.0 |
| LHPV4c1_b (L) | 3 | Glu | 27 | 5.1% | 0.6 |
| SLP364 (L) | 2 | Glu | 26 | 4.9% | 0.3 |
| KCg-s2 (L) | 1 | DA | 23 | 4.4% | 0.0 |
| SMP421 (L) | 1 | ACh | 21 | 4.0% | 0.0 |
| aMe23 (L) | 1 | Glu | 18 | 3.4% | 0.0 |
| SMP235 (L) | 1 | Glu | 17 | 3.2% | 0.0 |
| SLP066 (L) | 1 | Glu | 16 | 3.0% | 0.0 |
| LHPV4c1_a (L) | 1 | Glu | 16 | 3.0% | 0.0 |
| SLP210 (L) | 1 | ACh | 14 | 2.7% | 0.0 |
| LHPV4c2 (L) | 1 | Glu | 13 | 2.5% | 0.0 |
| SLP074 (L) | 1 | ACh | 13 | 2.5% | 0.0 |
| LHPD5a1 (L) | 1 | Glu | 12 | 2.3% | 0.0 |
| LHPV6m1 (L) | 1 | Glu | 10 | 1.9% | 0.0 |
| SMP427 (L) | 1 | ACh | 8 | 1.5% | 0.0 |
| CB1326 (L) | 2 | ACh | 7 | 1.3% | 0.1 |
| LHPV6h1 (L) | 2 | ACh | 7 | 1.3% | 0.1 |
| VP3+_vPN (L) | 1 | GABA | 6 | 1.1% | 0.0 |
| CB4124 (L) | 1 | GABA | 5 | 0.9% | 0.0 |
| SMP426 (L) | 1 | Glu | 4 | 0.8% | 0.0 |
| SMP345 (L) | 2 | Glu | 4 | 0.8% | 0.0 |
| SMP239 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| CB1901 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| SMP527 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| MeVC20 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| SLP313 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHPV4c4 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHPV6c1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHPV6q1 (L) | 1 | unc | 2 | 0.4% | 0.0 |
| LPN_a (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| WED092 (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| KCa'b'-ap1 (L) | 2 | DA | 2 | 0.4% | 0.0 |
| CB0656 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LPN_b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB4112 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB3308 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV6h1_b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP337 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP266 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP372 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| VP1m+VP2_lvPN2 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV4c1_c (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP402_a (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SMP183 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_ilPNm90 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP247 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| AVLP594 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
